- Artios attending 38th Annual J.P Morgan Healthcare Conference in San Francisco, January 12-16 2020
- Artios Pharma, MD Anderson and ShangPharma announce in-licensing agreement for DNA damage response inhibitor
- Artios Pharma appoints Tania Dimitrova as Chief Business Officer and expands presence in the United States
- Biotech CEO’s: Can Scientist Founders Remain in Charge?
- ‘Putting DNA repair on the map’- Artios CEO interviewed by Labiotech